Results for "TB/HIV"200

TB/HIV : a clinical manual / writing team: Anthony D. Harries, Dermot Maher and Stephen Graham ; with contributions from Charles Gilks ... [et al.]

World Health Organization

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa

Anthony D Harries, MD, PhD, Alexander PYM, MD

The overall aim of the project is to evaluate rifabutin (RBT) as a replacement for rifampicin (RMP), for the combined treatment of tuberculosis and HIV infection. RBT represents an alternative to RMP for HIV infected patients as its half-life is longer and the enzymatic induction…

Recommendations of the Interim Policy on Collaborative TB/HIV Activities = Activités communes contre la tuberculose et le VIH : recommandations au titre de la politique provisoire

World Health Organization

Ultrasound-guided lymph node biopsies: feasible and safe use of pathology services in a resource-limited, high TB/HIV prevalence setting.

Tapiwa Kumwenda, Veronica Phiri, Kelvin Rambik, Bianca Sossen, Tamiwe Tomoka, et al.

**BACKGROUND:** Enlarged lymph nodes (LN) pose diagnostic challenges for people with HIV (PWH). While tuberculosis (TB) is a common cause in low-income settings, lymphomas and Kaposi's sarcoma must also be considered. Ultrasound and symptoms cannot distinguish between these condi…

A Knowledge Translation Intervention for TB/HIV Treatment Adherence, in Zomba District, Malawi

Lisa Puchalski Ritchie

Despite increased emphasis on evidence based practice in recent years a gap remains between evidence and practice, particularly in resource poor countries. Few studies to date have examined the use of knowledge translation strategies to improve health care outcomes in low income …

Using joint models to study the association between CD4 count and the risk of death in TB/HIV data

Mchunu NN, Mwambi HG, Rizopoulos D, Reddy T, Yende-Zuma N

Background The association structure linking the longitudinal and survival sub-models is of fundamental importance in the joint modeling framework and the choice of this structure should be made based on the clinical background of the study. However, this information may not alwa…

Adalimumab for Corticosteroid and Infliximab-Resistant Immune Reconstitution Inflammatory Syndrome in the Setting of TB/HIV Coinfection

Lwin N, Boyle M, Davis JS

Corticosteroids are the mainstay of therapy for immune reconstitution inflammatory syndrome (IRIS). However, little is known about how to treat IRIS unresponsive to steroids. We report a patient with HIV-TB coinfection who was unresponsive to first prednisolone and then inflixima…

TB/HIV research priorities in resource-limited settings : report of an expert consultation, 14-15 February 2005, Geneva, Switzerland

UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, Stop TB Partnership

Non-tuberculous mycobacterial disease in a high TB/HIV burden setting

Saskia Janssen, Zul Izhar Mohd Ismail, Thomas Lovelock, Sarah Hugo, Marije Van Schalkwyk, et al.

Contains fulltext : 322446.pdf (Publisher’s version ) (Open Access)

Expression of mycobacterium tuberculosis induced SOCS3 and STAT3 and the implications on innate immunity in TB patients vs healthy contacts in high TB/HIV endemic setting: A cross-sectional analytical study

Lungu P, Mushota K, Njelesani E, Sukwa T, Lakhi S, et al.

Background Mycobacterium tuberculosis (TB) remains a disease of global health concern and a leading cause of mortality arising from an infectious agent. Protective immunity to TB remains unclear. Suppressor of cytokine signaling-3 (SOCS3) and signal transduction and activator of …

Drug-induced hepatotoxicity among TB/HIV co-infected patients in a referral hospital, Ethiopia

Zeleke A, Misiker B, Yesuf TA

Objectives Anti-tuberculosis drug-induced hepatotoxicity is a common serious adverse drug reaction. This study intended to determine the prevalence and associated factors of drug-induced hepatotoxicity among tuberculosis and human immunodeficiency virus co-infected patients in De…

Management of collaborative TB/HIV activities : training for managers at the national and subnational levels

López, Rafael Alberto, Migliori, Giovanni Battista, Bergström, Karin, Norval, Pierre-Yves, World Health Organization, et al.

Promoting the implementation of collaborative TB/HIV activities through public-private mix and partnerships: report of a WHO consultation 27-28 February 2008, WHO headquarters, Geneva, Switzerland

World Health Organization

Scaling up prevention and treatment for TB and HIV: global TB/HIV working group of the Stop TB partnership, Addis Ababa, Ethiopia, 20-21 September 2004

World Health Organization

Unravelling the population structure and transmission patterns of <i>Mycobacterium tuberculosis</i> in Mozambique, a high TB/HIV burden country

Belén Saavedra, Mariana G. López, Álvaro Chiner‐Oms, Ana María García García, Irving Cancino‐Muñoz, et al.

Abstract Genomic studies of Mycobacterium tuberculosis complex (MTBC) might shed light on the dynamics of its transmission, especially in high-burden settings, where recent outbreaks are embedded in the complex natural history of the disease. We applied Whole-genome sequencing (W…

Tuberculosis and HIV : a framework to address TB/HIV co-infection in the Western Pacific Region

World Health Organization. Regional Office for the Western Pacific

Priority research questions for tuberculosis/human immunodeficiency virus (TB/HIV) in HIV-prevalent and resource-limited settings

World Health Organization

Working together with businesses : guidance on TB and TB/HIV prevention, diagnosis, treatment and care in the workplace

World Health Organization, UNAIDS, International Labour Organization

Organizational contextual factors that predict success of a quality improvement collaborative approach to enhance integrated HIV-tuberculosis services: a sub-study of the Scaling up TB/HIV Integration trial

Gengiah S, Connolly C, Yende-Zuma N, Barker PM, Nunn AJ, et al.

Background A quality improvement (QI) collaborative approach to enhancing integrated HIV-Tuberculosis (TB) services may be effective in scaling up and improving the quality of service delivery. Little is known of the role of organizational contextual factors (OCFs) in influencing…

Clinicodemographic profile and outcome of tuberculosis treatment in TB-HIV co-infected patients receiving daily ATT under a single window TB/HIV services delivery initiative

Maji D, Agarwal U, Kumar L, V V, Sharma A

The risk of death in HIV-TB coinfected individuals is far greater than in HIV-only patients. It is critical to provide timely and appropriate therapy in HIV-TB coinfected patients in order to reduce morbidity and mortality. The purpose of this study was to evaluate the clinical p…

The twin epidemics: Prevalence of TB/HIV co-infection and its associated factors in Ethiopia; A systematic review and meta-analysis

Tesfaye B, Alebel A, Gebrie A, Zegeye A, Tesema C, et al.

Background Tuberculosis and HIV/AIDS are the major public health problems in many parts of the world particularly in resource limited countries like Ethiopia. Although studies have been conducted on the prevalence and associated factors of TB / HIV co-infection in Ethiopia, there…

Incidence of death and its predictors among TB/HIV coinfected adult patients receiving anti-retroviral therapy at Gambelia referral hospital, Southwest Ethiopia, 2022.

Endeshaw Habtamu Wolelaw, Endalk Getasew Hiruy, Asiya Mohammed Abdu, Kebadnew Mulatu Mihretie

**BACKGROUND:** In patients who have tuberculosis and the human immunodeficiency virus, Tuberculosis is the most prevalent opportunistic illness and the main cause of death. However, little is currently, the time to death and its predictors are known, particularly among individua…